We are live on
!
Find out more
LMF
LMR Master Fund Portfolio holdings
AUM
$968M
This Fund
S&P 500
This Quarter
Est. Return
+13.41%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$523M
AUM Growth
-$585M
(-53%)
Cap. Flow
-$649M
Cap. Flow
% of AUM
-123.95%
Top 10 Holdings %
Top 10 Hldgs %
28.73%
Holding
549
New
95
Increased
32
Reduced
167
Closed
254
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$18.4M |
| 2 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$9.68M |
| 3 |
Universal Health Services
UHS
|
+$9.5M |
| 4 |
ONIT
Onity Group
ONIT
|
+$8.69M |
| 5 |
TW
TOWERS WATSON & CO COM STK CL A (DE)
TW
|
+$8.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI South Korea ETF
EWY
|
+$37.5M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$26.9M |
| 3 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$26.9M |
| 4 |
AT&T
T
|
+$26.7M |
| 5 |
NLSN
Nielsen Holdings plc
NLSN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.25% |
| 2 | Healthcare | 15.21% |
| 3 | Technology | 13.61% |
| 4 | Financials | 12.47% |
| 5 | Consumer Discretionary | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Vanda Pharmaceuticals
VNDA
$307M
| $182K | 0.03% |
+16,582
| New | +$177K |
|
277
United States Antimony
UAMY
$751M
| $177K | 0.03% |
127,598
-47,358
| -27% | -$56.5K |
|
278
BioCryst Pharmaceuticals
BCRX
$2.28B
| $159K | 0.03% |
21,844
-88,835
| -80% | -$451K |
|
279
Repligen
RGEN
$7.96B
| $159K | 0.03% |
+14,309
| New | +$142K |
|
|
SMPL
280
DELISTED
SIMPLICITY BANCORP INC
SMPL
| $157K | 0.03% |
10,043
-9,450
| -48% | -$142K |
|
|
CBNJ
281
DELISTED
CAPE BANCORP, INC COM
CBNJ
| $154K | 0.03% |
16,860
-11,543
| -41% | -$108K |
|
|
XOMA
282
DELISTED
Xoma
XOMA
| $149K | 0.03% |
+1,654
| New | +$150K |
|
283
First Horizon
FHN
$12.2B
| $143K | 0.03% |
13,036
-280,581
| -96% | -$3.31M |
|
284
Talphera
TLPH
$66.4M
| $138K | 0.03% |
+644
| New | +$141K |
|
285
QuickLogic
QUIK
$232M
| $134K | 0.03% |
3,651
-6,583
| -64% | -$232K |
|
286
Pacific Biosciences
PACB
$435M
| $126K | 0.02% |
+22,809
| New | +$79.2K |
|
|
ELON
287
DELISTED
Echelon Corp
ELON
| $107K | 0.02% |
4,473
-7,888
| -64% | -$176K |
|
|
CALD
288
DELISTED
Callidus Software, Inc.
CALD
| $99K | 0.02% |
+10,767
| New | +$81.3K |
|
|
MAXY
289
DELISTED
MAXYGEN INC
MAXY
| $92K | 0.02% |
36,493
-29,858
| -45% | -$75K |
|
|
RLOG
290
DELISTED
Rand Logistics, Inc.
RLOG
| $88K | 0.02% |
17,997
-24,367
| -58% | -$124K |
|
|
IDXG
291
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
| $58K | 0.01% |
120
-156
| -57% | -$74.7K |
|
292
AXT Inc
AXTI
$3.95B
| $55K | 0.01% |
23,595
-52,504
| -69% | -$131K |
|
293
Innodata
INOD
$2.05B
| $43K | 0.01% |
16,797
-26,007
| -61% | -$72.2K |
|
|
TURN
294
DELISTED
180 Degree Capital
TURN
| $40K | 0.01% |
4,469
-24,444
| -85% | -$226K |
|
|
ADGE
295
DELISTED
American Dg Energy Inc
ADGE
| $35K | 0.01% |
22,392
-18,546
| -45% | -$29.5K |
|
296
Accenture
ACN
$102B
| – | – |
-6,375
| Closed | -$459K |
|
297
First Majestic Silver
AG
$7.41B
| – | – |
-90,665
| Closed | -$960K |
|
|
AGEN
298
Agenus
AGEN
$312M
| – | – |
-2,580
| Closed | -$192K |
|
|
AIV
299
Aimco
AIV
$387M
| – | – |
-218,583
| Closed | -$875K |
|
300
Akamai
AKAM
$16.7B
| – | – |
-17,848
| Closed | -$759K |
|
Similar funds
UGIF
KF
CP
WSA
SCIA
SMU
PAI
IC
LMR Master Fund's Q3 2013 Portfolio in Review
As of Q3 2013, LMR Master Fund held 549 positions worth $523M, down 53% from $1.11B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
LMR Master Fund withdrew a net $649M in Q3 2013, closing 254 positions and reducing 167 holdings. Its most notable exit was iShares MSCI South Korea ETF, an estimated $37.5M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
Against the trend, LMR Master Fund opened a new position in PHARMACYCLICS INC worth $12.1M.
- LMR Master Fund's largest Q3 2013 buy was PHARMACYCLICS INC: 87,269 shares worth $12.1M.
- LMR Master Fund added most to Walt Disney in Q3 2013, an estimated $18.4M increase.
- LMR Master Fund's biggest Q3 2013 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $26.9M.
- LMR Master Fund fully exited iShares MSCI South Korea ETF in Q3 2013, selling an estimated $37.5M.
- LMR Master Fund's ten largest holdings make up 29% of its $523M portfolio in Q3 2013.
- LMR Master Fund opened 95 new positions and closed 254 in Q3 2013.
- LMR Master Fund's portfolio value fell 53% quarter-over-quarter to $523M.
Based on LMR Master Fund's 13F filing for Q3 2013, filed 14 Nov 2013.